Hematopoietic growth factors in the pathogenesis and for the treatment of aplastic anemia

Seminars in Hematology

Volumn 37, Issue 1, 2000, Pages 81-90

  Marsh, Judith C W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; OXYMETHOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; DRUG INDUCED DISEASE; HUMAN; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

EID: 0033966143     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90032-5     Document Type: Article

References (86)

1. Abkowitz JL, Hume H, Yancik SA, et al: Stem cell factor serum levels may not be clinically relevant. Blood 87:4017-4018, 1996
2. Antin JH, Smith BR, Holmes W, et al: Phase I/II study of rhGM-CSF in aplastic anemia and myelodysplastic syndromes. Blood 72:705-713, 1988
3. Atkins MB, Kappler K, Mier JW, et al: Interleukin-6 associated anemia: Determination of the underlying mechanism. Blood 86:1288-1291, 1995
4. Bacigalupo A, Biaggio G, Figari O, et al: Response of CFU-GM to increasing doses of rhGM-CSF in patients with aplastic anemia. Exp Hematol 19:829-834, 1991
5. Bacigalupo A, Broccia G, Corda G, et al: Antilymphocyte globulin, cyclosporin and granulocyte colony stimulating factor in patients with acquired severe aplastic anaemia (SAA): A pilot study of the EBMT SAA Working Party. Blood 85:1348-1353, 1995
6. Bacigalupo A, Piaggio G, Podesta M, et al: Collection of peripheral blood haemopoietic progenitors (PBHP) from patients with severe aplastic anemia (SAA) after prolonged administration of granulocyte colony stimulating factor. Blood 82:1410-1414, 1993
7. Bagnara GP, Strippoli P, Bonsi L: Effect of stem cell factor on colony growth from acquired and constitutional (Fanconi) aplastic anaemia. Blood 80:382-387, 1992
8. Ball SE, Gibson FM, Rizzo S, et al: Progressive telomere shortening in aplastic anemia. Blood 91:3582-3592, 1998
9. Bessho M, Hirashima K, Asano S, et al: Treatment of anaemia of aplastic anaemia patients with rh EPO in combination with G-CSF: A multicenter randomised controlled study. Eur J Haematol 58:265-272, 1997
10. Brereton ML, Adams JA, Briggs M, et al: The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemia. Br J Med 104:119-126, 1999
11. Champlin RE, Nimer SD, Ireland P, et al: Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony stimulating factor. Blood 73:694-699, 1989
12. DePlanque M, Bacigalupo A, Wursch A, et al: Long term follow up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). Br J Haematol 73:121-126, 1989
13. Devetten MP, Young NS: Hemopoietic growth factors in the pathophysiology and treatment of aplastic anemia, in Ganser A, Hoelzer D (eds): Cytokines in the Treatment of Hemopoietic Failure. New York, NY, Marcel Dekker, 1999, pp 155-169
14. Doney K, Storb R, Lilleby K, et al: Recombinant interleukin-1 followed by immunosuppressive therapy for aplastic anemia. Am J Hematol 52:61-62, 1996
15. Emmons RVB, Reid DM, Cohen RL, et al: Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068-4071, 1996
16. Engelhardt M, Ozkaynak MF, Drulinsky P, et al: Telomere activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 12:13-24, 1998
17. Ganser A, Lindermann A, Seipelt G, et al: Effect of recombinant human interleukin-3 in aplastic anemia. Blood 76:1287-1292, 1990
18. Gascon P, Scala G: Decreased interleukin-1 production in aplastic anemia. Am J Med 85:668-674, 1988
19. Geary CG, Marsh JCW: Is aplastic anaemia, a pre-leukaemic disorder? Br J Haematol 77:447-452, 1991
20. Gibson FM, Gordon-Smith EC: Long term culture of aplastic anaemia bone marrow. Br J Haematol 75:421-427, 1990
21. Gibson FM, Scopes J, Daly S, et al: In vitro response of normal and aplastic anaemia bone marrow to mast cell growth factor and in combination with granulocyte macrophage colony stimulating factor and interleukin-3. Exp Hematol 22:302-312, 1994
22. Gluckman E, Esperou-Bourdeau H, Boogaerts BM, et al: Multicenter randomized study comprising cyclosporin A alone and antithymocyte globulin with prednisolone for treatment of aplastic anemia. Blood 79:2540-2546, 1992
23. Gluckman E, Rokicka-Milewska R, Gordon-Smith EC, et al: Results of a randomized study of glycosylated rHuG-CSF Lenograstim in severe aplastic anemia. Blood 92:1551, 1998 (suppl 1, abstr)
24. Guinan EC, Sieff CA, Oette DH, et al: A phase I/II trial of recombinant granulocyte-macrophage colony stimulating factor for children with aplastic anemia. Blood 76:1077-1082, 1990
25. Hirayama Y, Kohgo Y, Matsunaga T, et al: Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anaemia and myelodysplastic syndrome. Br J Haematol 85:676-683, 1993
26. Hirayama Y, Sakamaki S, Matsunaga T, et al: Concentrations of thrombopoietin in bone marrow in normal subjects, and in patients with idiopathic thrombocytopenic purpura, aplastic anemia and essential thrombocythemia correlates with its mRNA expression of bone marrow stromal cells. Blood 92:46-52, 1998
27. Holmberg LA, Seidel K, Leisenring W et al: Aplastic anemia: Analysis of stromal cell function in long term marrow culture. Blood 84:3685-3690, 1994
28. Imashuku S, Hibi S, Kataoka MY, et al: Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. Br J Haematol 89:188-191, 1995
29. Kaito K, Kobayashi M, Katayama T, et al: Long term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol 103:297-303, 1998
30. Kojima S: Hemopoietic growth factors and marrow stroma in aplastic anemia. Int J Hematol 68:19-28, 1998
31. Kojima S, Fukuda M, Miyajima Y, et al: Treatment of aplastic anemia in children with recombinant human granulocyte-colony stimulating factor. Blood 77:937-941, 1991
32. Kojima S, Matsuyama T: Stimulation of granulopoiesis by high-dose recombinant human granulocyte colony stimulating factor in children with aplastic anemia and very severe neutropenia. Blood 83:1474-1478, 1994
33. Kojima S, Matsuyama T, Kodera Y: Hemopoietic growth factors released from marrow stromal cells from patients with aplastic anemia. Blood 79:2256-2261, 1992
34. Kojima S, Matsuyama T, Kodera Y, et al: Measurement of endogenous plasma granulocyte colony stimulating factor in patients with acquired aplastic anemia by a sensitive chemiluminescent immunoassay. Blood 87:1303-1308, 1996
35. Kojima S, Matsuyama T, Kodera Y, et al: Measurement of endogenous plasma thrombopoietin in patients with acquired aplastic anaemia by a sensitive enzyme-linked immunoabsorbent assay. Br J Haematol 97:538-543, 1997
36. Kojima S, Matsuyama T, Kodera Y: Plasma levels and production of soluble stem cell factor by marrow stromal cells in patients with aplastic anaemia. Br J Haematol 99:440-446, 1997
37. Kojima S, Tsuchida M, Matsuyama T: Myelodysplasia and leukemia after treatment of aplastic anemia with granulocyte colony stimulating factor. N Engl J Med 326:1294-1295, 1992
38. Kumar M, Alter BP: Hemopoietic growth factors for the treatment of aplastic anaemia. Curr Opin Hematol 5:226-234, 1998
39. Kurzrock R, Paquette R, Gratwohl A, et al: Use of stem cell factor (Stemgen, SCF) and filgrastim (G-CSF) in aplastic anemia patients who have failed ATG/ALG therapy. Blood 90:173, 1997 (suppl 1, abstr)
40. Kurzrock R, Talpaz M, Estrov Z, et al: Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J Clin Oncol 9:1241-1250, 1991
41. Maciejewski JP, Anderson S, Katevos P, et al: Phenotypic and functional analysis of the bone marrow progenitor cell compartment in aplastic anaemia. Br J Haematol 87:227-233, 1994
42. Maciejewski JP, Selleri C, Sato T, et al: A severe and consistent defect in marrow and circulating primitive hemopoietic cells (long term culture initiating cells) in acquired aplastic anemia. Blood 88:1983-1991, 1996
43. Marsh JCW, Chang J, Testa NG, et al: In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol 78:258-267, 1991
44. Marsh JCW, Chang J, Testa NG, et al: The haemopoietic defect in aplastic anaemia assessed by long term marrow culture. Blood 76:1748-1757, 1990
45. Marsh JCW, Gibson FM, Prue RL, et al: Serum thrombopoietin levels in patients with aplastic anaemia. Br J Haematol 95:605-610, 1996
46. Marsh JCW, Socie G, Schrezenmeier H, et al: Haemopoietic growth factors in aplastic anaemia: A cautionary note. Lancet 344:172-173, 1994
47. Marsh JCW, Testa NG: Stem cell defect in aplastic anaemia, in Schrezenmeier H, Bacigalupo A (eds): Aplastic Anaemia. Cambridge, UK, Cambridge University Press, 1999, pp 2-20
48. Martin SJ, Green DR: Apoptosis and cancer: The failure of controls on cell death and cell survival. Crit Opin Hematol 18:137-153, 1995
49. Nakao S, Matsushima K, Young N: Deficient interleukin-1 production by aplastic anaemia monocytes. Br J Haematol 71:431-433, 1989
50. Nash RA, Burstein SA, Storb R, et al: Thrombocytopenia in dogs induced by granulocyte-macrophage colony stimulating factor: Increased destruction of circulating platelets. Blood 86:1765-1775, 1995
51. Nimer SD, Leung DHY, Wolin MJ, et al: Serum stem cell factor levels in patients with aplastic anemia. Int J Hematol 60:185-189, 1994
52. Nimer SD, Paquette RL, Ireland P, et al: A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Exp Hematol 22:875-880, 1994
53. Nissen C, Tichelli A, Gratwohl A, et al: Failure of rhGM-CSF therapy in aplastic anemia patients with very severe neutropenia. Blood 72:2045-2046, 1988
54. Nissen C, Wodnar-Filipowicz A, Slanicka Krieger M, et al: Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse. Eur J Haematol 55:255-261, 1995
55. Notaro R, Cimmino A, Tabanni D, et al: In vivo telomere dynamics of human hemopoietic stem cells. Proc Nad Acad Sci USA 94:13782-13785, 1997
56. Novitsky N, Jacobs P: Immunosuppressive therapy in bone marrow aplasia: The stroma functions normally to support hemopoiesis. Exp Hematol 23:1472-1477, 1995
57. Ohara A, Kojima S, Hamajima N, et al: Myelodysplasia and acute myeloid leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 90:1009-1013, 1997
58. Philpott NJ, Scopes J, Marsh JCW, et al: Increased apoptosis in aplastic anemia bone marrow progenitor cells: Possible padiophysiological significance. Exp Haematol 23:1642-1648, 1995
59. Podesta M, Paggio G, Frassoni F, et al: Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation. Bone Marrow Transplant 19:1011-1017, 1997
60. Raghavachar A, Ganser A, Freund M, et al: Long term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia. Cytokines Mol Ther 2:215-223, 1996
61. Rosenfeld S, Kinball J, Vining D, et al: Superior result of combination immunosuppressive therapy with antithymocyte globulin and cyclosporine A in severe aplastic anemia. Blood 85:3058-3064, 1995
62. Schrezenmeier H, Jenal M, Hermann F, et al: Quantitative analysis of cobblestone area forming cells in bone marrow of patients with aplastic anemia by limiting dilution assay. Blood 88:4474-4480, 1996
63. Schrezenmeier H, Marsh JCW, Stromeyer P, et al: A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia. Br J Haematol 90:283-292, 1995
64. Schrezenmeier H, Noe G, Raghavachar A, et al: Serum erythropoietin and serum transferin receptor levels in aplastic anaemia. Br J Haematol 88:286-294, 1994
65. Schrezenmeier H, Raghavachar A, Heimpel: Granulocyte-macrophage colony stimulating factor in the serum of patients with aplastic anemia. Clin Invest 71:102-108, 1993
66. Scopes J, Bagnara M, Gordon-Smith EC, et al: Haemopoietic progenitor cells are reduced in aplastic anaemia. Br J Haematol 81:427-430, 1994
67. Scopes J, Daly S, Atkinson R, et al: Aplastic anemia: Evidence for dysfunctional bone marrow progenitor cells and the corrective effect of granulocyte colony stimulating factor in vitro. Blood 87:3179-3185, 1996
68. Slanicka-Krieger M, Nissen C, et al: Stem cell factor in aplastic anaemia: In vitro expression in bone marrow stroma and fibroblast cultures. Eur J Haematol 54:262-269, 1995
69. Socie G, Henry AM, Bacigalupo A, et al: Malignant tumours occurring after treatment of aplastic anemia. European Bone Marrow Transplant Severe Aplastic Anemia Working Party. N Engl J Med 329:1152-1157, 1993
70. Sonoda Y, Ohno Y, Fujii H, et al: Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor). Stem Cells 11:543-554, 1993
71. Sonoda Y, Yashige H, Fujii H, et al: Bilineage response in refractory aplastic anemia patients following long term administration of recombinant human granulocyte-macrophage colony stimulating factor. Eur J Haematol 48:41-44, 1992
72. Stark R, Andre C, Thierry D, et al: The expression of cytokine and cytokine receptor genes in long term bone marrow culture in congenital and acquired marrow hypoplasias. Br J Haematol 83:560-566, 1993
73. Takahashi M, Yoshida Y, Kaku K, et al: Phase II study of recombinant human granulocyte colony stimulating factor in myelodysplastic syndrome and aplastic anemia. Acta Haematol 89:189-194, 1993
74. Testa NG, de Wynter EA, Weaver A: The study of hemopoietic stem cells in patients: Concepts, approaches and cautionary tales. Ann Oncol 7:5-8, 1996 (suppl 2, abstr)
75. Tichelli A, Gratwohl A, Wursch A, et al: Late haematological complications in severe aplastic anaemia. Br J Haematol 69:413-418, 1988
76. Vadhan-Raj S, Buerscher S, Broxmeyer HE, et al: Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage stimulating factor. N Engl J Med 319:1628-1634, 1988
77. Vaziri H, Dragowska W, Allsopp RC, et al: Evidence for a mitotic clock in human hemopoietic stem cells: Loss of telomere DNA with age. Proc Nad Acad Sci USA 91:9857-9860, 1994
78. Walsh CE, Liu JM, Anderson SM, et al: A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anaemia. Br J Haematol 80:106-110, 1992
79. Weite K, Gabrilove J, Bronchud MH, et al: Filgrastim (r-metHuG-CSF): The first 10 years. Blood 88:1907-1929, 1996
80. Wodmar-Filipowicz A, Chlouskaia E, Manz CY, et al: Effect of flt3 ligand on in vitro growth and expansion of colony forming bone marrow cells from patients with aplastic anemia. Exp Hematol 25:573-581, 1997
81. Wodnar-Filipowicz A, Lyman SD, Gratwohl A, et al: Flt-3 ligand level reflects hemopoietic progenitor cell function in aplastic anemia and chemotherapy induced bone marrow aplasia. Blood 88:4493-4499, 1996
82. Wodnar-Filipowicz A, Yancik S, Moser Y, et al: Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood 81:3259-3264, 1993
83. Wynn RF, Cross MA, Hatton C, et al: Accelerated telomere shortening in young recipients of allogeneic bone marrow transplants. Lancet 351:178-181, 1998
84. Wynn RF, Cross MA, Testa NG: Telomeres and haemopoiesis. Br J Haematol 103:591-593, 1998
85. Young NS, Barrett AJ: The treatment of severe acquired aplastic anemia. Blood 85:3367-3377, 1995
86. Young NS, Maciejewski J: The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365-1372, 1997